Protective effect of stobadine on NCV in streptozotocin-diabetic rats: Augmentation by vitamin E

General Physiology and Biophysics

Volumn 27, Issue 2, 2008, Pages 106-114

  Skalska, Silvia ^a   Kyselova, Z ^a   Gajdosikova, A ^a   Karasu, C ^b   Stefek, M ^a   Stolc, S ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Diabetes; Neuropathy; Oxidative stress; Rats; Stobadine

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; HYDROVIT E FORTE; STOBADINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; IN VITRO STUDY; ISCHEMIA; MALE; MONOTHERAPY; MOTOR NERVE CONDUCTION; NERVE CONDUCTION DISORDER; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; CARBOLINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; DIETARY SUPPLEMENTS; DRUG INTERACTIONS; MALE; NEURAL CONDUCTION; RATS; RATS, WISTAR; STREPTOZOCIN; VITAMIN E; VITAMINS;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 48749127716     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Archibald V., Cotter M. A., Keegan A., Cameron N. E. (1996): Contraction and relaxation of aortas from diabetic rats: effects of chronic antioxidant and aminoguanidine treatments. Naunyn Schmiedebergs Arch. Pharmacol. 353, 584-591
2. Baba M., Nukada H., McMorran D., Takahashi K., Wada R., Yagihashi S. (2006): Prolonged ischemic conduction failure after reperfusion in diabetic nerve. Muscle Nerve 33, 350-355
3. Baynes J. W. (1991): Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412
4. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. (1990): Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U.S.A. 87, 1620-1624
5. Biró K., Jednákovits A., Kukorelli T., Hegedüs E., Korányi L. (1997): Bimoclomol BRLP-42 ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Brain Res. Bull. 44, 259-263
6. Camera A., Hopp S. E., Caimi G. (2008): Diabetic microangiopathy: physiological, clinical and therapeutic aspects. Curr. Drug Targets 9, 94-100
7. Cameron N. E., Cotter M. A. (1994): Effects of evening primrose oil treatment on sciatic nerve blood flow and endoneural oxygen tension in streptozotocin-diabetic rats. Diabetologia 31, 220-225
8. Cameron N. E., Cotter M. A. (1995): Mechanisms underlying impaired nerve perfusion and endoneurial oxygenation in experimental diabetes. In: Diabetic Neuropathy: New Concepts and Insights. (Eds. N. Hotta, D. A. Greene, J. D. Ward, A. A. F. Sima and A. J. M. Boulton), pp. 3-15, Elsevier, Amsterdam
9. Cameron N. E., Cotter M. A. (1999): Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45, 137-146
10. Cameron N. E., Cotter M. A., Robertson S. (1991): Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes 40, 532-539
11. Cameron N. E., Cotter M. A., Dines K., Love A. (1992): Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 35, 946-950
12. Cameron N. E., Cotter M. A., Dines K. C., Maxfield E. K. (1993): Pharmacological manipulation of vascular endothelium function in non-diabetic and streptozotocin-diabetic rats: effects on nerve conduction, hypoxic resistance and endoneurial capillarization. Diabetologia 36, 516-522
13. Cameron N. E., Cotter M. A., Basso M., Hohman T. C. (1997): Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 40, 271-281
14. Coppey L. J., Gellet J. S., Davidson E. P., Dunlap J. A., Lund D. D., Salvemini D., Yorek M. A. (2001): Effect of M40403 treatment of diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Br. J. Pharmacol. 134, 21-29
15. Cotter M. A., Love A., Watt M. J., Cameron N. E., Dines K. C. (1995): Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia 38, 1285-1294
16. Eaton R. P., Qualls C., Bicknell J., Sibbitt W. L. Jr., King M. K., Griffey R. H. (1996): Structure-function relationships within peripheral nerves in diabetic neuropathy: the hydration hypothesis. Diabetologia 39, 439-446
17. Horakova L., Stolc S. (1998): Antioxidant and pharmacodynamic effects of pyridoindole stobadine. Gen. Pharmacol. 30, 627-638
18. Kagan V. E., Tsuchiya M., Serbinova E., Packer L., Sies H. (1993): Interaction of the pyridoindole stobadine with peroxyl, superoxide and chromanoxyl radicals. Biochem. Pharmacol. 45, 393-400
19. Larsen M. O., Wilken M., Gotfredsen C. F., Carr R. D., Svendsen O., Rolin B. (2002): Mild streptozotocin diabetes in the Göttingen minipig. A novel model of moderate insulin deficiency and diabetes. Am. J. Physiol. 282, E1342-1351
20. Lattimer S. A., Sima A. A. F., Greene D. A. (1989): In vitro correction of impaired Na,K-ATPase in diabetic nerve by protein kinase C agonists. Am. J. Physiol. 256, E264-269
21. Love A., Cotter M. A., Cameron N. E. (1997): Effects of a-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats. Naunyn Schmied. Arch. Pharmacol. 355, 126-130
22. Low P. A., Nickander K. K. (1991): Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40, 873-877
23. Low P. A., Ward K., Schmelzer J. D., Brimijoin S. (1985): Ischaemic conduction failure and energy metabolism in experimental diabetic neuropathy. Am. J. Physiol. 248, 457-462
24. Low P. A., Lagerlund T. D., McManis P. G. (1989): Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31, 355-438
25. Nangle M. R., Gisson T. M., Cotter M. A., Cameron N. E. (2006): Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med. 72, 494-500
26. Nickander K. K., Schmeltzer J. D., Rohwer D. A., Low P. A. (1994): Effect of α-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J. Neurol. Sci. 126, 6-14
27. 2+/ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim. Biophys. Acta 1588, 71-78
28. Pieper G. M., Langenstroer P., Gross G. J. (1993): Hydroxyl radicals mediate injury to endothelium-dependent relaxation in diabetic rats. Mol. Cell. Biochem. 122, 139-145
29. Pop-Busui R., Sima A., Stevens M. (2006): Diabetic neuropathy and oxidative stress. Diabetes Metab. Res. Rev. 22, 257-273
30. Rackova L., Stefek M., Majekova M. (2002): Structural aspects of antioxidant activity of substituted pyridoindoles. Redox Rep. 7, 207-214
31. Sango K., Horie H., Okamura A., Inoue S., Takenaka T. (1995): Diabetes impairs DRG neuronal attachment to extracellular matrix protein in vitro. Brain Res. Bull. 37, 533-537
32. Schmeltzer J. D., Zochodne D. W., Low P. A. (1989): Ischemic and reperfusion injury of rat peripheral nerve. Proc. Natl. Acad. Sci. U.S.A. 86, 1639-1642
33. Sima A. A. F., Sugimoto K. (1999): Experimental diabetic neuropathy: an update. Diabetologia 42, 773-788
34. Sima A. A., Prashar A., Nathaniel V., Bril V., Werb M. R., Greene D. A. (1993): Overt diabetic neuropathy: Repair of axoglial dysjuntion and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity. Diabet. Med. 10, 115-121
35. Sotnikova R., Stefek M., Okruhlicova L., Navarova J., Bauer V., Gajdosik A., Gajdosikova A. (2001): Dietary supplementation of the pyridoindole antioxidant stobadine reduces vascular impairment in streptozotocin-diabetic rats. Methods Find. Exp. Clin. Pharmacol. 23, 121-129
36. Sotnikova R., Skalska S., Okruhlicova L., Navarova J., Kyselova Z., Zurova J., Stefek M., Hozova R., Nosalova V. (2006): Changes in the function and ultrastructure of vessels in the rat model of multiple low dose streptozotocin-induced diabetes. Gen. Physiol. Biophys. 25, 289-302
37. Steenken S., Sundquist A. R., Jovanovic S. V., Crockett R., Sies H. (1992): Antioxidant activity of the pyridoindole stobadine. Pulse radiolytic characterisation of one-electron oxidized stobadine and quenching of singlet molecular oxygen. Chem. Res. Toxicol. 5, 355-360
38. Stefek M., Drozdikova I., Vajdova K. (1996): The pyridoindole antioxidant stobadine inhibited glycation-induced absorbance and fluorescence changes in albumin. Acta Diabetol. 33, 35-40
39. Stefek M., Sotnikova R., Okruhlicova L., Volkovova K., Kucharska J., Gajdosik A., Gajdosikova A., Mihalova D., Hozova R., Tribulova N., Gvozdjakova A. (2000): Effect of dietary supplementation with the pyridoindole antioxidant stobadine on antioxidant state and ultrastructure of diabetic rat myocardium. Acta Diabetol. 37, 111-117
40. Stefek M., Gajdosik A., Tribulova N., Navarova J., Volkovova K., Weismann P., Gajdosikova A., Drimal J., Mihalova D. (2002): The pyridoindole antioxidant stobadine attenuates albuminuria, enzymuria, kidney lipid peroxidation and matrix collagen crosslinking in streptozotocin-induced diabetic rats. Methods Find. Exp. Clin. Pharmacol. 24, 565-571
41. Strupp M., Jund R., Schneider U., Grafe P. (1991): Glucose availability and sensitivity to anoxia of isolated rat peroneal nerve. Am. J. Physiol. 261, E389-394
42. Ulusu N. N., Sahilli M., Avci A., Canbolat O., Ozansoy G., Ari N., Bali M., Stefek M., Stolc S., Gajdosik A., Karasu C. (2003): Pentose phosphate pathway, glutathione-dependent enzymes and antioxidant defense during oxidative stress in diabetic rodent brain and peripheral organs: effects of stobadine and vitamin E. Neurochem. Res. 28, 815-823
43. Taylor P. D., Poston L. (1994): The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br. J. Pharmacol. 113, 801-808
44. Terata K., Coppey L. J., Davidson E. P., Dunlap J. A., Gutterman D. D., Yorek M. A. (1999): Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br. J. Pharmacol. 128, 837-843
45. van Dam P. S., Bravenboer B. (1997): Oxidative stress and antioxidant treatment in diabetic neuropathy. Neurosci. Res. Commun. 21, 41-48
46. van Dam P. S., van Asbeck B. S., Erkelens D. W., Marx J. J. M., Gisppen W. H., Bravenboer B. (1995): The role of oxidative stress in neuropathy and other diabetic complications. Diabetes/Metab. Rev. 1, 181-192
47. van Dam P. S., Bravenboer B., van Asbeck B. S., Marx J. J., Gispen W. H. (1999): High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. Eur. J. Pharmacol. 376, 217-222
48. Wang Y., Schmelzer J. D., Schmeichel A., Iida H., Low P. A. (2004): Ischemia-reperfusion injury of peripheral nerve in experimental diabetic neuropathy. J. Neurol. Sci. 227, 101-107
49. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G. (1993): Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42, 801-813
50. Wright R. A., Nukada H. (1995): Nerve metabolism, physiology and pathology in mature STZ-diabetic rat. In: Diabetic Neuropathy: New Concepts and Insights. (Eds. N. Hotta, D. A. Greene, J. D. Ward, A. A. F. Sima and A. J. M. Boulton), pp. 147-151, Elsevier, Amsterdam